Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide
Clinical trial NCT01458366 · COMPLETED
Trial details
- NCT number
- NCT01458366
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-09
- Primary completion
- 2018-08-27
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.